2025年全球动物生技药品市场报告

预计未来几年兽用生技药品的市场规模将强劲成长。到 2029 年，这一数字将成长至 183.8 亿美元，复合年增长率为 7.7%。预测期内的增长可归因于新兴感染疾病、气候变迁和疾病模式、精准畜牧业、单一健康方法以及宠物饲养趋势的增加。预测期内的关键趋势包括教育和培训计划、环保和永续生技药品、数位健康记录的整合、伴同性生技药品的兴起以及客製化的标靶治疗。

预计动物疾病的激增将推动兽用生技药品市场的成长。动物疾病涵盖影响多种动物物种的多种疾病。这些疾病的增加凸显了对先进诊断和治疗解决方案的需求，而采用免疫学方法对抗和管理动物疾病的兽医生技药品正在满足这一需求。截至2022年10月，欧洲疾病预防控制中心已通报2,467例家禽禽流感病例，影响4,800万隻鸟。对此，世界卫生组织（WHO）2022年7月透露，狂犬病每年在150多个国家夺走5.9万人的生命，其中95%在非洲和亚洲。动物疾病的激增是推动生物製药市场发展的关键因素。

预计宠物收养趋势将对兽医生技药品市场的成长做出重大贡献。宠物收养通常涉及承担收容所或救援组织对农场动物的责任，并提供永久的、充满关怀的住所。兽用生技药品在预防感染疾病、提供免疫力、控制通用感染疾病、延长寿命和提高生活品质、降低兽医护理成本、改善宠物生殖功能以及提供更有针对性和个性化的治疗方案方面发挥着至关重要的作用。根据美国宠物产品协会发布的2023年10月资料，66%的美国家庭（总合8,690万户）拥有宠物，高于2022年的62%。宠物拥有量的快速成长是兽用生技药品市场扩张的主要因素。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球动物生技药品PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
• 最终用途产业分析
• 全球动物生技药品市场：成长率分析
• 全球动物生技药品市场表现：规模与成长，2019-2024
• 全球动物生技药品市场预测：2024-2029 年及 2034 年规模与成长
• 全球动物生技药品总目标市场（TAM）

第六章市场区隔

• 全球动物生技药品市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 疫苗
• 诊断试剂套件
• 免疫调节药物
• 抗血清和抗体
• 其他产品
• 全球动物生技药品市场（依疾病类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
• 蓝舌病
• 口蹄疫
• 布氏桿菌症和结核病
• 其他疾病
• 全球动物生技药品市场（依通路）：现况及预测（2019-2024 年、2024-2029 年及 2034 年）
• 兽医诊所
• 兽医诊所
• 其他分销管道
• 全球动物生技药品市场应用、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
• 生产动物
• 宠物
• 全球动物生技药品市场，按类型细分：疫苗，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 减毒活疫苗
• 灭活疫苗
• 重组疫苗
• DNA疫苗
• 全球动物生技药品市场，按类型细分：诊断试剂套件，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 快速检测
• 酵素连结免疫吸附测定套件
• PCR诊断试剂套件
• 全球动物生技药品市场，按类型细分：免疫调节剂，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 细胞激素
• 佐剂
• 免疫刺激剂
• 全球动物生技药品市场，按类型细分：抗血清和抗体，实际和预测，2019-2024 年、2024-2029 年、2034 年
• 单株抗体
• 多株抗体
• 超免疫血清
• 全球动物生技药品市场，按类型细分：其他产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 益生菌
• 益生元
• 生长因子
• 类毒素

第七章 区域和国家分析

• 全球动物生技药品市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球动物生技药品市场：依国家、地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 动物生技药品市场：竞争格局
• 动物生技药品市场：公司简介
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly & Company Overview, Products and Services, Strategy and Financial Analysis
  • Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Boehringer Ingelheim Animal Health Inc.
• Elanco Animal Health
• IDEXX Laboratories Inc.
• Virbac SA
• Phibro Animal Health Corporation
• Vetoquinol
• Abaxis Inc.
• Bimeda Biologicals
• Ceva Sante Animale SA
• Heska Corporation
• Colorado Serum Company
• Hester Biosciences Limited
• INDICAL Bioscience GmbH
• Ambrx Biopharma Inc.
• Adamis Pharmaceuticals Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年动物生技药品市场：提供新机会的国家
• 2029年动物生技药品市场：细分领域带来新机会
• 2029年动物生技药品市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Veterinary biologics encompass biological products obtained from living organisms such as viruses, bacteria, or other microorganisms. These specialized products in veterinary medicine serve to prevent, diagnose, or treat diseases in animals.

Key products falling under veterinary biologics include vaccines, diagnostic kits, immunomodulators, antiserums, antibodies, and related items. Vaccines, for instance, are formulated to trigger the immune system's response and offer protection against specific animal diseases. They address various ailments such as bluetongue, foot and mouth disease, brucellosis, tuberculosis, and others. These products are distributed through multiple channels, including veterinary hospitals and clinics, for diverse applications involving both production and companion animals.

The veterinary biologics market research report is one of a series of new reports from The Business Research Company that provides veterinary biologics market statistics, including veterinary biologics industry global market size, regional shares, competitors with a veterinary biologics market share, detailed veterinary biologics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary biologics industry. This veterinary biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary biologics market size has grown strongly in recent years. It will grow from $12.67 billion in 2024 to $13.65 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to animal disease outbreaks, regulatory support and standards, demand for food safety, globalization of trade, and economic significance of livestock

The veterinary biologics market size is expected to see strong growth in the next few years. It will grow to $18.38 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to emerging infectious diseases, climate change and disease patterns, precision livestock farming, one health approach, and increased pet ownership trends. Major trends in the forecast period include education and training programs, eco-friendly and sustainable biologics, integration of digital health records, rise in companion animal biologics, and customized and targeted therapies.

The upsurge in the prevalence of animal diseases is anticipated to be a driving force behind the growth of the veterinary biologics market. Animal diseases encompass a range of illnesses affecting diverse animal species. The escalation in these diseases underscores the need for advanced diagnostic and treatment solutions, a demand met by veterinary biologics that employ immunological methods to address and manage animal diseases. As of October 2022, the European Center for Disease Prevention and Control reported 2,467 outbreaks of avian influenza in poultry, impacting 48 million birds, with an additional 187 cases observed in captive birds. In a related context, the World Health Organization disclosed in July 2022 that rabies claims the lives of 59,000 people annually across over 150 countries, with a predominant 95% of cases concentrated in Africa and Asia. This surge in animal diseases is a pivotal factor propelling the veterinary biologics market.

The increasing trend of pet adoption is poised to contribute significantly to the growth of the veterinary biologics market. Pet adoption involves assuming responsibility for a domesticated animal, often from shelters or rescue organizations, to provide a permanent and caring home. Veterinary biologics play a crucial role in preventing infectious diseases in pets, offering immunity, controlling zoonotic diseases, enhancing lifespan and quality of life, reducing veterinary healthcare costs, improving reproductive health in pets, and providing more targeted and customized treatment options. Data from October 2023, as reported by the American Pet Products Association, reveals that 66% of U.S. households, totaling 86.9 million, own a pet-an increase from 62% in 2022. This surge in pet adoption is a significant driver behind the expanding veterinary biologics market.

Leading companies in the veterinary biologics market are concentrating on the development of innovative biologics, such as vaccines, to improve animal health and prevent diseases. A vaccine is a substance that triggers the immune system to recognize and combat specific pathogens, helping to prevent infectious diseases by providing acquired immunity. For example, in August 2024, Merck Animal Health, a global animal health company based in the U.S., launched an experimental autogenous vaccine targeting avian metapneumovirus (aMPV) type B, which received approval from the U.S. Department of Agriculture (USDA) for manufacturing and sale. Created in partnership with Cambridge Technologies, this vaccine aims to address the serious respiratory problems caused by aMPV type B in poultry, which have resulted in significant economic losses since late 2023. Manufactured at a state-of-the-art facility in Minnesota, the vaccine uses an oil and water emulsion formulation designed to reduce post-vaccination tissue reactions, filling a crucial gap in the market as there were previously no commercially licensed vaccines available.

Companies at the forefront of the veterinary biologics market are also channeling their efforts into the creation of innovative products, such as injections designed to control pain associated with osteoarthritis (OA) in dogs. These injections target canine nerve growth factors, providing an effective means to alleviate the pain that dogs experience due to osteoarthritis. Zoetis Inc., a distinguished U.S.-based animal health company, secured approval from the U.S. Food and Drug Administration (FDA) for Librela (bedinvetmab injection) in May 2023. Positioned as the first and only monthly anti-NGF monoclonal antibody medication for canine OA pain, Librela stands out as a safe and efficacious solution for managing long-term OA pain symptoms in dogs. This approval underscores Librela's role in enhancing the mobility and overall well-being of canines grappling with osteoarthritis, contributing to an improved quality of life for these animals.

In January 2024, Ceva Sante Animale, a pharmaceutical company based in France, acquired Scout Bio for an undisclosed amount. This acquisition enhances Ceva's biotechnology capabilities and speeds up its innovation in pet therapeutics, particularly targeting advanced treatments for chronic diseases. This strategic move responds to the growing demand for better health solutions among pet owners. Scout Bio is a biotechnology company located in the U.S. that specializes in providing essential data for the development of effective veterinary biologics, including vaccines and diagnostics.

Major companies operating in the veterinary biologics market include Bayer AG, Eli Lilly & Company, Evonik Industries AG, Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Vetoquinol, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics

North America was the largest region in the veterinary biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The veterinary biologics market consists of sales of transplant tissues, recombinant proteins, and stem cells. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Biologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Vaccines; Diagnostic Kits; Immunomodulators; Antiserums And Antibodies; Other Products
• 2) By Disease Type: Bluetongue; Foot And Mouth Disease; Brucellosis And Tuberculosis; Other Diseases
• 3) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Other Distribution Channels
• 4) By Application: Production Animal; Companion Animal
• Subsegments:
• 1) By Vaccines: Live Attenuated Vaccines; Inactivated Vaccines; Recombinant Vaccines; DNA Vaccines
• 2) By Diagnostic Kits: Rapid Tests; Elisa Kits; Pcr-Based Diagnostic Kits
• 3) By Immunomodulators: Cytokines; Adjuvants; Immunostimulants
• 4) By Antiserums And Antibodies: Monoclonal Antibodies; Polyclonal Antibodies; Hyperimmune Serums
• 5) By Other Products: Probiotics; Prebiotics; Growth Factors; Toxoids
• Companies Mentioned: Bayer AG; Eli Lilly & Company; Evonik Industries AG; Zoetis Inc.; Merck Animal Health Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Biologics Market Characteristics

3. Veterinary Biologics Market Trends And Strategies

4. Veterinary Biologics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Veterinary Biologics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Biologics Market Growth Rate Analysis
• 5.4. Global Veterinary Biologics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Biologics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Biologics Total Addressable Market (TAM)

6. Veterinary Biologics Market Segmentation

• 6.1. Global Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Diagnostic Kits
• Immunomodulators
• Antiserums And Antibodies
• Other Products
• 6.2. Global Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bluetongue
• Foot And Mouth Disease
• Brucellosis And Tuberculosis
• Other Diseases
• 6.3. Global Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Veterinary Clinics
• Other Distribution Channels
• 6.4. Global Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Production Animal
• Companion Animal
• 6.5. Global Veterinary Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Vaccines
• Inactivated Vaccines
• Recombinant Vaccines
• DNA Vaccines
• 6.6. Global Veterinary Biologics Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rapid Tests
• Elisa Kits
• Pcr-Based Diagnostic Kits
• 6.7. Global Veterinary Biologics Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cytokines
• Adjuvants
• Immunostimulants
• 6.8. Global Veterinary Biologics Market, Sub-Segmentation Of Antiserums And Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Polyclonal Antibodies
• Hyperimmune Serums
• 6.9. Global Veterinary Biologics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Probiotics
• Prebiotics
• Growth Factors
• Toxoids

7. Veterinary Biologics Market Regional And Country Analysis

• 7.1. Global Veterinary Biologics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Biologics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Biologics Market

• 8.1. Asia-Pacific Veterinary Biologics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Biologics Market

• 9.1. China Veterinary Biologics Market Overview
• 9.2. China Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Biologics Market

• 10.1. India Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Biologics Market

• 11.1. Japan Veterinary Biologics Market Overview
• 11.2. Japan Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Biologics Market

• 12.1. Australia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Biologics Market

• 13.1. Indonesia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Biologics Market

• 14.1. South Korea Veterinary Biologics Market Overview
• 14.2. South Korea Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Biologics Market

• 15.1. Western Europe Veterinary Biologics Market Overview
• 15.2. Western Europe Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Biologics Market

• 16.1. UK Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Biologics Market

• 17.1. Germany Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Biologics Market

• 18.1. France Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Biologics Market

• 19.1. Italy Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Biologics Market

• 20.1. Spain Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Biologics Market

• 21.1. Eastern Europe Veterinary Biologics Market Overview
• 21.2. Eastern Europe Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Biologics Market

• 22.1. Russia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Biologics Market

• 23.1. North America Veterinary Biologics Market Overview
• 23.2. North America Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Biologics Market

• 24.1. USA Veterinary Biologics Market Overview
• 24.2. USA Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Biologics Market

• 25.1. Canada Veterinary Biologics Market Overview
• 25.2. Canada Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Biologics Market

• 26.1. South America Veterinary Biologics Market Overview
• 26.2. South America Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Biologics Market

• 27.1. Brazil Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Biologics Market

• 28.1. Middle East Veterinary Biologics Market Overview
• 28.2. Middle East Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Biologics Market

• 29.1. Africa Veterinary Biologics Market Overview
• 29.2. Africa Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Biologics Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Biologics Market Competitive Landscape
• 30.2. Veterinary Biologics Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eli Lilly & Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Biologics Market Other Major And Innovative Companies

• 31.1. Boehringer Ingelheim Animal Health Inc.
• 31.2. Elanco Animal Health
• 31.3. IDEXX Laboratories Inc.
• 31.4. Virbac SA
• 31.5. Phibro Animal Health Corporation
• 31.6. Vetoquinol
• 31.7. Abaxis Inc.
• 31.8. Bimeda Biologicals
• 31.9. Ceva Sante Animale S.A.
• 31.10. Heska Corporation
• 31.11. Colorado Serum Company
• 31.12. Hester Biosciences Limited
• 31.13. INDICAL Bioscience GmbH
• 31.14. Ambrx Biopharma Inc.
• 31.15. Adamis Pharmaceuticals Corporation

32. Global Veterinary Biologics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Biologics Market

34. Recent Developments In The Veterinary Biologics Market

35. Veterinary Biologics Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Biologics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Biologics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Biologics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer